Biodesix (BDSX) Stock Statistics & Valuation Metrics

Biodesix has a market cap or net worth of $209.08M. The enterprise value is $185.95.

Biodesix has 10,355,809 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biodesix’s return on equity (ROE) is 14.31 and return on invested capital (ROIC) is -38.88%.

The current PE Ratio of Biodesix is ―. Biodesix’s PEG ratio is 0.05.

In the last 12 months, Biodesix had revenue of 88.50M and earned -35.27M in profits. Earnings per share was -4.67.

In the last 12 months, operating cash flow was -24.84M and capital expenditures -411.00K, giving a free cash flow of -25.25M billion.

Biodesix pays an annual dividend of ―, resulting in a dividend yield of ―

Biodesix upcoming earnings date is Aug 12, 2026, After Close (Confirmed).

Biodesix as a current ratio of 1.86, with Debt / Equity ratio of 784.17%

In the past 12 months, Biodesix has paid 0.00 in taxes.

Biodesix EV to EBITDA ratio is -4.79, with an EV/FCF ratio of -4.44.

Biodesix has $25.57M in cash and marketable securities with $71.61M in debt, giving a net cash position of -$46.04M billion.

Gross margin is 82.08%, with operating margin of -31.37%, and net profit margin of -39.85%.

The average price target for Biodesix is $31.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy